Rory Kelleher
Rory Kelleher is the global business development lead for healthcare and life sciences at NVIDIA. He’s responsible for building strategic engagements in pharma, healthcare research, and insurance markets to transform their businesses through deep learning and GPU-accelerated applications. In his spare time, he enjoys the outdoors, experiencing new cultures, and various athletic activities.
US Healthcare System Deploys AI Agents, From Research to Rounds
Editor’s note: The name of NIM Agent Blueprints was changed to NVIDIA Blueprints in October 2024. All references to the name have been updated in this blog. The U.S. healthcare system… Read Article
Drug Discovery, STAT! NVIDIA, Recursion Speed Pharma R&D With AI Supercomputer
Described as the largest system in the pharmaceutical industry, BioHive-2 at the Salt Lake City headquarters of Recursion debuts today at No. 35, up more than 100 spots from its… Read Article
NVIDIA CEO: ‘This Year, Every Industry Will Become a Technology Industry’
“This year, every industry will become a technology industry,” NVIDIA founder and CEO Jensen Huang told attendees Wednesday during the annual J.P. Morgan Healthcare Conference. “You can now recognize and… Read Article
Amgen to Build Generative AI Models for Novel Human Data Insights and Drug Discovery
Generative AI is transforming drug research and development, enabling new discoveries faster than ever — and Amgen, one of the world’s leading biotechnology companies, is tapping the technology to power… Read Article
NVIDIA Collaborates With Genentech to Accelerate Drug Discovery Using Generative AI
Genentech, a member of the Roche Group, is pioneering the use of generative AI to discover and develop new therapeutics and deliver treatments to patients more efficiently. A new collaboration… Read Article
Mitsui and NVIDIA Announce Japan’s First Generative AI Supercomputer for Pharmaceutical Industry
Mitsui & Co., Ltd., one of Japan’s largest business conglomerates, is collaborating with NVIDIA on Tokyo-1 — an initiative to supercharge the nation’s pharmaceutical leaders with technology, including high-resolution molecular… Read Article
From Genomes to Proteins to Cells, Digital Biology Revolution Marches on with HPC and AI
Scientists and healthcare researchers — once limited by the number of samples that could be studied in a wet lab, or the quality of microscopes to peer into cells —… Read Article
Mass General’s Martinos Center Adopts AI for COVID, Radiology Research
Academic medical centers worldwide are building new AI tools to battle COVID-19 — including at Mass General, where one center is adopting NVIDIA DGX A100 AI systems to accelerate its… Read Article